文献速递泌尿生殖妇产影像MR

定量动态增强MRI鉴别卵巢良性、交界性与恶性肿瘤

Quantitative dynamic contrast-enhanced MR imaging for differentiating benign, borderline, and malignant ovarian tumors.
PubMed 文献 · Abdom Radiol (NY) · 2018-01-01

前瞻性研究评估定量DCE-MRI参数(Ktrans、kep、ve)在15例良性、28例交界性、66例恶性卵巢肿瘤及28例I型与29例II型上皮性卵巢癌中的鉴别价值;卵巢恶性肿瘤Ktrans和kep值最大,交界性次之,良性最小(均P<0.001);kep鉴别良性vs交界性及恶性最优,kep联合可提高鉴别交界性与恶性的敏感度至78.9%。

要点

  • kep鉴别良性vs交界性肿瘤的AUC为0.94,敏感度89.3%、特异度86.7%。
  • kep鉴别良性vs恶性肿瘤的AUC为0.992,敏感度95.5%、特异度100%。
  • Ktrans鉴别交界性vs恶性肿瘤的AUC为0.743,联合kep敏感度提高至78.9%。

核心结论

  • 定量DCE-MRI联合全肿瘤体积ROI技术可行,可用于鉴别卵巢肿瘤及区分I型与II型上皮性卵巢癌。

研究设计与样本

  • 前瞻性研究,纳入15例良性、28例交界性、66例恶性卵巢肿瘤,其中上皮性卵巢癌I型28例、II型29例;采用全实性肿瘤体积ROI法,基于改良Tofts模型计算定量参数。

诊断标准与关键数值

  • kep鉴别良性vs交界性肿瘤:敏感度89.3%、特异度86.7%、准确率88.4%、AUC 0.94。
  • kep鉴别良性vs恶性肿瘤:敏感度95.5%、特异度100%、准确率96.3%、AUC 0.992。
  • Ktrans鉴别交界性vs恶性肿瘤:敏感度60.7%、特异度78.8%、准确率73.4%、AUC 0.743。
  • Ktrans联合kep鉴别交界性vs恶性肿瘤:敏感度提高至78.9%。

临床应用与阅片要点

  • 卵巢恶性肿瘤Ktrans和kep值最大,交界性次之,良性最小(均P<0.001)。
  • II型上皮性卵巢癌Ktrans和kep中位值显著高于I型。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: This study aimed to investigate the diagnostic performance of quantitative DCE-MRI for characterizing ovarian tumors.

METHODS: We prospectively assessed the differences of quantitative DCE-MRI parameters (Ktrans, kep, and ve) among 15 benign, 28 borderline, and 66 malignant ovarian tumors; and between type I (n = 28) and type II (n = 29) of epithelial ovarian carcinomas (EOCs). DCE-MRI data were analyzed using whole solid tumor volume region of interest (ROI) method, and quantitative parameters were calculated based on a modified Tofts model. The non-parametric Kruskal-Wallis test, Mann-Whitney U test, Pearson's chi-square test, intraclass correlation coefficient (ICC), variance test, and receiver operating characteristic curves (ROC) were used for statistical analysis.

RESULTS: The largest Ktrans and kep values were observed in ovarian malignant tumors, followed by borderline and benign tumors (all P < 0.001). Kep was the better parameter for differentiating benign tumors from borderline and malignant tumors, with a sensitivity of 89.3% and 95.5%, a specificity of 86.7% and 100%, an accuracy of 88.4% and 96.3%, and an area under the curve (AUC) of 0.94 and 0.992, respectively, whereas Ktrans was better for differentiating borderline from malignant tumors with a sensitivity of 60.7%, a specificity of 78.8%, an accuracy of 73.4%, and an AUC of 0.743. In addition, a combination with kep could further improve the sensitivity to 78.9%. The median Ktrans and kep values were significantly higher in type II than in type I EOCs.

CONCLUSION: DCE-MRI with volume quantification is a technically feasible method, and can be used for the differentiation of ovarian tumors and for discriminating between type I and type II EOCs.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Li HM, Feng F, Qiang JW, et al. Quantitative dynamic contrast-enhanced MR imaging for differentiating benign, borderline, and malignant ovarian tumors. Abdom Radiol (NY). 2018. PMID: 29556691. doi:10.1007/s00261-018-1569-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。